ID   MDFA_ECOLI              Reviewed;         410 AA.
AC   P0AEY8; P71226; P75807; Q46966;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   15-MAR-2017, entry version 96.
DE   RecName: Full=Multidrug transporter MdfA;
DE   AltName: Full=Chloramphenicol resistance pump Cmr;
GN   Name=mdfA; Synonyms=cmlA, cmr; OrderedLocusNames=b0842, JW0826;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=8655497; DOI=10.1128/jb.178.11.3188-3193.1996;
RA   Nilsen I.W., Bakke I., Vader A., Olsvik O., El-Gewely M.R.;
RT   "Isolation of cmr, a novel Escherichia coli chloramphenicol resistance
RT   gene encoding a putative efflux pump.";
RL   J. Bacteriol. 178:3188-3193(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=ATCC 33694 / HB101;
RX   PubMed=9079913; DOI=10.1128/jb.179.7.2274-2280.1997;
RA   Edgar R., Bibi E.;
RT   "MdfA, an Escherichia coli multidrug resistance protein with an
RT   extraordinarily broad spectrum of drug recognition.";
RL   J. Bacteriol. 179:2274-2280(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8905232; DOI=10.1093/dnares/3.3.137;
RA   Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A.,
RA   Ikemoto K., Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K.,
RA   Kimura S., Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K.,
RA   Mori H., Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N.,
RA   Sampei G., Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y.,
RA   Yano M., Horiuchi T.;
RT   "A 718-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 12.7-28.0 min region on the linkage map.";
RL   DNA Res. 3:137-155(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   FUNCTION.
RC   STRAIN=K12 / C600 / ATCC 23724 / DSM 3925 / LMG 3041 / NCIB 10222;
RX   PubMed=9811673;
RA   Bohn C., Bouloc P.;
RT   "The Escherichia coli cmlA gene encodes the multidrug efflux pump
RT   Cmr/MdfA and is responsible for isopropyl-beta-D-thiogalactopyranoside
RT   exclusion and spectinomycin sensitivity.";
RL   J. Bacteriol. 180:6072-6075(1998).
RN   [7]
RP   FUNCTION AS AN ANTIPORTER, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=9644262; DOI=10.1093/oxfordjournals.jbchem.a022078;
RA   Mine T., Morita Y., Kataoka A., Mizushima T., Tsuchiya T.;
RT   "Evidence for chloramphenicol/H+ antiport in Cmr (MdfA) system of
RT   Escherichia coli and properties of the antiporter.";
RL   J. Biochem. 124:187-193(1998).
RN   [8]
RP   TOPOLOGY.
RX   PubMed=10022825; DOI=10.1093/emboj/18.4.822;
RA   Edgar R., Bibi E.;
RT   "A single membrane-embedded negative charge is critical for
RT   recognizing positively charged drugs by the Escherichia coli multidrug
RT   resistance protein MdfA.";
RL   EMBO J. 18:822-832(1999).
RN   [9]
RP   FUNCTION.
RX   PubMed=12578981; DOI=10.1073/pnas.0435544100;
RA   Lewinson O., Adler J., Poelarends G.J., Mazurkiewicz P.,
RA   Driessen A.J., Bibi E.;
RT   "The Escherichia coli multidrug transporter MdfA catalyzes both
RT   electrogenic and electroneutral transport reactions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:1667-1672(2003).
RN   [10]
RP   MUTAGENESIS OF GLU-26.
RX   PubMed=14717607; DOI=10.1021/bi035485t;
RA   Adler J., Lewinson O., Bibi E.;
RT   "Role of a conserved membrane-embedded acidic residue in the multidrug
RT   transporter MdfA.";
RL   Biochemistry 43:518-525(2004).
RN   [11]
RP   FUNCTION IN ALKALITOLERANCE.
RX   PubMed=15371593; DOI=10.1073/pnas.0405375101;
RA   Lewinson O., Padan E., Bibi E.;
RT   "Alkalitolerance: a biological function for a multidrug transporter in
RT   pH homeostasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14073-14078(2004).
RN   [12]
RP   TOPOLOGY [LARGE SCALE ANALYSIS].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   "Global topology analysis of the Escherichia coli inner membrane
RT   proteome.";
RL   Science 308:1321-1323(2005).
RN   [13]
RP   SUBUNIT.
RX   PubMed=17407265; DOI=10.1021/bi602405w;
RA   Sigal N., Lewinson O., Wolf S.G., Bibi E.;
RT   "E. coli multidrug transporter MdfA is a monomer.";
RL   Biochemistry 46:5200-5208(2007).
RN   [14]
RP   SUBSTRATE-BINDING.
RX   PubMed=19808670; DOI=10.1074/jbc.M109.050658;
RA   Fluman N., Cohen-Karni D., Weiss T., Bibi E.;
RT   "A promiscuous conformational switch in the secondary multidrug
RT   transporter MdfA.";
RL   J. Biol. Chem. 284:32296-32304(2009).
CC   -!- FUNCTION: Efflux pump driven by the proton motive force. Confers
CC       resistance to a broad spectrum of chemically unrelated drugs.
CC       Confers resistance to a diverse group of cationic or zwitterionic
CC       lipophilic compounds such as ethidium bromide,
CC       tetraphenylphosphonium, rhodamine, daunomycin, benzalkonium,
CC       rifampicin, tetracycline, puromycin, and to chemically unrelated,
CC       clinically important antibiotics such as chloramphenicol,
CC       erythromycin, and certain aminoglycosides and fluoroquinolones.
CC       Overexpression results in isopropyl-beta-D-thiogalactopyranoside
CC       (IPTG) exclusion and spectinomycin sensitivity. Transport of
CC       neutral substrates is electrogenic, whereas transport of cationic
CC       substrates is electroneutral. In addition to its role in multidrug
CC       resistance, confers extreme alkaline pH resistance, allowing the
CC       growth under conditions that are close to those used normally by
CC       alkaliphiles. This activity requires Na(+) or K(+).
CC       {ECO:0000269|PubMed:12578981, ECO:0000269|PubMed:15371593,
CC       ECO:0000269|PubMed:9079913, ECO:0000269|PubMed:9644262,
CC       ECO:0000269|PubMed:9811673}.
CC   -!- ENZYME REGULATION: Inhibited by CCCP.
CC       {ECO:0000269|PubMed:9644262}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.5. {ECO:0000269|PubMed:9644262};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:17407265}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane; Multi-pass membrane
CC       protein.
CC   -!- MISCELLANEOUS: A negative charge at position 26 is required for
CC       efficient transport of positively charged substrates, but not for
CC       neutral compounds. This negative charge does not play an essential
CC       role in the multidrug transport mechanism.
CC   -!- MISCELLANEOUS: Has a sensitive conformational switch that can be
CC       triggered either by substrate binding or by attaching unrelated
CC       agents inside the pocket. Dissimilar substrates induce similar
CC       conformational changes.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. MdfA
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U44900; AAC44147.1; -; Genomic_DNA.
DR   EMBL; Y08743; CAA69997.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73929.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA35546.1; -; Genomic_DNA.
DR   PIR; B64822; B64822.
DR   RefSeq; NP_415363.1; NC_000913.3.
DR   RefSeq; WP_001180089.1; NZ_LN832404.1.
DR   PDB; 4ZOW; X-ray; 2.45 A; A=10-400.
DR   PDB; 4ZP0; X-ray; 2.00 A; A=9-400.
DR   PDB; 4ZP2; X-ray; 2.20 A; A=9-400.
DR   PDBsum; 4ZOW; -.
DR   PDBsum; 4ZP0; -.
DR   PDBsum; 4ZP2; -.
DR   ProteinModelPortal; P0AEY8; -.
DR   SMR; P0AEY8; -.
DR   BioGrid; 4262828; 106.
DR   DIP; DIP-48116N; -.
DR   IntAct; P0AEY8; 1.
DR   MINT; MINT-1227586; -.
DR   STRING; 511145.b0842; -.
DR   BindingDB; P0AEY8; -.
DR   ChEMBL; CHEMBL4785; -.
DR   TCDB; 2.A.1.2.19; the major facilitator superfamily (mfs).
DR   PaxDb; P0AEY8; -.
DR   PRIDE; P0AEY8; -.
DR   EnsemblBacteria; AAC73929; AAC73929; b0842.
DR   EnsemblBacteria; BAA35546; BAA35546; BAA35546.
DR   GeneID; 945448; -.
DR   KEGG; ag:CAA69997; -.
DR   KEGG; ecj:JW0826; -.
DR   KEGG; eco:b0842; -.
DR   PATRIC; 32116889; VBIEscCol129921_0870.
DR   EchoBASE; EB3460; -.
DR   EcoGene; EG13696; mdfA.
DR   eggNOG; ENOG4107QF7; Bacteria.
DR   eggNOG; ENOG410XT98; LUCA.
DR   HOGENOM; HOG000118215; -.
DR   InParanoid; P0AEY8; -.
DR   KO; K08160; -.
DR   OMA; MQTHANR; -.
DR   PhylomeDB; P0AEY8; -.
DR   BioCyc; EcoCyc:CMR-MONOMER; -.
DR   BioCyc; MetaCyc:CMR-MONOMER; -.
DR   PRO; PR:P0AEY8; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IDA:EcoCyc.
DR   GO; GO:0015238; F:drug transmembrane transporter activity; IMP:EcoCyc.
DR   GO; GO:0015386; F:potassium:proton antiporter activity; IDA:EcoCyc.
DR   GO; GO:0015385; F:sodium:proton antiporter activity; IDA:EcoCyc.
DR   GO; GO:0006855; P:drug transmembrane transport; IMP:EcoCyc.
DR   GO; GO:0030641; P:regulation of cellular pH; IMP:EcoCyc.
DR   GO; GO:0046677; P:response to antibiotic; IMP:EcoCyc.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; Cell inner membrane;
KW   Cell membrane; Complete proteome; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    410       Multidrug transporter MdfA.
FT                                /FTId=PRO_0000173331.
FT   TOPO_DOM      1     14       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     15     32       Helical. {ECO:0000305}.
FT   TOPO_DOM     33     53       Periplasmic. {ECO:0000305}.
FT   TRANSMEM     54     72       Helical. {ECO:0000305}.
FT   TOPO_DOM     73     82       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     83    103       Helical. {ECO:0000305}.
FT   TOPO_DOM    104    109       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    110    130       Helical. {ECO:0000305}.
FT   TOPO_DOM    131    144       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    145    165       Helical. {ECO:0000305}.
FT   TOPO_DOM    166    166       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    167    187       Helical. {ECO:0000305}.
FT   TOPO_DOM    188    226       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    227    247       Helical. {ECO:0000305}.
FT   TOPO_DOM    248    255       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    256    276       Helical. {ECO:0000305}.
FT   TOPO_DOM    277    287       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    288    308       Helical. {ECO:0000305}.
FT   TOPO_DOM    309    314       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    315    335       Helical. {ECO:0000305}.
FT   TOPO_DOM    336    346       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    347    367       Helical. {ECO:0000305}.
FT   TOPO_DOM    368    378       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    379    399       Helical. {ECO:0000305}.
FT   TOPO_DOM    400    410       Cytoplasmic. {ECO:0000305}.
FT   MUTAGEN      26     26       E->A: Loss of ethidium bromide efflux
FT                                activity. {ECO:0000269|PubMed:14717607}.
FT   MUTAGEN      26     26       E->D: No change in ethidium bromide
FT                                efflux activity.
FT                                {ECO:0000269|PubMed:14717607}.
FT   MUTAGEN      26     26       E->H: Almost no chloramphenicol efflux
FT                                activity. Loss of ethidium bromide efflux
FT                                activity. {ECO:0000269|PubMed:14717607}.
FT   MUTAGEN      26     26       E->I,V: Slight decrease in
FT                                chloramphenicol efflux activity. Exhibits
FT                                low ethidium bromide efflux activity.
FT                                {ECO:0000269|PubMed:14717607}.
FT   MUTAGEN      26     26       E->K: Decrease in TPP efflux activity.
FT                                Exhibits low ethidium bromide efflux
FT                                activity. {ECO:0000269|PubMed:14717607}.
FT   MUTAGEN      26     26       E->L,N: Strong decrease in
FT                                chloramphenicol efflux activity. Loss of
FT                                ethidium bromide and TPP efflux
FT                                activities.
FT                                {ECO:0000269|PubMed:14717607}.
FT   MUTAGEN      26     26       E->Q: Slight decrease in chloramphenicol
FT                                efflux activity. Loss of ethidium bromide
FT                                efflux activity.
FT                                {ECO:0000269|PubMed:14717607}.
FT   MUTAGEN      26     26       E->T: Strong decrease in chloramphenicol
FT                                efflux activity. Loss of ethidium bromide
FT                                efflux activity.
FT                                {ECO:0000269|PubMed:14717607}.
FT   CONFLICT     59     59       T -> N (in Ref. 2; CAA69997).
FT                                {ECO:0000305}.
FT   CONFLICT    225    240       ALALGFVSLPLLAWIA -> GAGAADSLVCRCWRGSP (in
FT                                Ref. 1; AAC44147). {ECO:0000305}.
FT   STRAND       11     13       {ECO:0000244|PDB:4ZP2}.
FT   HELIX        14     16       {ECO:0000244|PDB:4ZP2}.
FT   HELIX        17     34       {ECO:0000244|PDB:4ZP0}.
FT   HELIX        36     46       {ECO:0000244|PDB:4ZP0}.
FT   HELIX        53     65       {ECO:0000244|PDB:4ZP0}.
FT   HELIX        69     79       {ECO:0000244|PDB:4ZP0}.
FT   HELIX        81     98       {ECO:0000244|PDB:4ZP0}.
FT   HELIX        99    101       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       105    116       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       117    120       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       121    124       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       126    133       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       136    165       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       170    191       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       205    216       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       219    246       {ECO:0000244|PDB:4ZP0}.
FT   TURN        247    249       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       254    278       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       279    281       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       284    308       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       313    339       {ECO:0000244|PDB:4ZP0}.
FT   HELIX       346    398       {ECO:0000244|PDB:4ZP0}.
SQ   SEQUENCE   410 AA;  44321 MW;  D4466EE680095773 CRC64;
     MQNKLASGAR LGRQALLFPL CLVLYEFSTY IGNDMIQPGM LAVVEQYQAG IDWVPTSMTA
     YLAGGMFLQW LLGPLSDRIG RRPVMLAGVV WFIVTCLAIL LAQNIEQFTL LRFLQGISLC
     FIGAVGYAAI QESFEEAVCI KITALMANVA LIAPLLGPLV GAAWIHVLPW EGMFVLFAAL
     AAISFFGLQR AMPETATRIG EKLSLKELGR DYKLVLKNGR FVAGALALGF VSLPLLAWIA
     QSPIIIITGE QLSSYEYGLL QVPIFGALIA GNLLLARLTS RRTVRSLIIM GGWPIMIGLL
     VAAAATVISS HAYLWMTAGL SIYAFGIGLA NAGLVRLTLF ASDMSKGTVS AAMGMLQMLI
     FTVGIEISKH AWLNGGNGLF NLFNLVNGIL WLSLMVIFLK DKQMGNSHEG
//
